title: Unusual ischemic complication of bevacizumab treatment for metastatic colorectal carcinoma.
authors.affiliation: Beaumont Hospital, Dublin, Ireland.
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Ryan
authors.forename: Ann
authors.initials: A
authors.lastname: Hanly
authors.forename: Martina M
authors.initials: MM
authors.lastname: Morrin
authors.forename: Deborah A
authors.initials: DA
authors.lastname: McNamara
mesh_terms: D015746:Abdominal Pain / Q000209:etiology*; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab; D001646:Bile; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002767:Cholecystostomy; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003125:Colostomy; D004322:Drainage / Q000379:methods; D005472:Fluorouracil / Q000008:administration & dosage; D005704:Gallbladder / Q000098:blood supply*; D006801:Humans; D007511:Ischemia / Q000139:chemically induced* / Q000150:complications; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil